Literature DB >> 8565131

Expression of hepatocyte growth factor and c-met mRNAs during rat chemically induced hepatocarcinogenesis.

T Imai1, T Masui, H Nakanishi, K Inada, K Kobayashi, T Nakamura, M Tatematsu.   

Abstract

The receptor for hepatocyte growth factor (HGF), a potent hepatocyte mitogen, is the product of the protooncogene c-met. In order to cast light on their significance for hepatocarcinogenesis, levels of both HGF and c-met mRNA were evaluated in rat livers during development of 2-acetylaminofluorene (2-AAF)-selected preneoplastic nodules and carcinomas following diethylnitrosamine (DEN) initiation. Rats were given a single i.p. injection of 200 mg/kg body wt DEN and, starting 2 weeks later, were administered 0.015% 2-AAF in the diet for up to 6 weeks. All rats were subjected to partial hepatectomy (PH) at week 3. Additional animals undergoing the DEN, 2-AAF and PH regimen were sacrificed at week 40 to allow evaluation of carcinomas. Oval cell proliferation, glutathione S-transferase placental form (GST-P)-positive preneoplastic lesion development and HGF and c-met mRNA levels were sequentially analyzed after PH. Numerous oval cells were observed 1 week after PH, but were remarkably reduced 2 weeks thereafter. The areas of GST-P-positive foci and nodules rapidly increased with time not only during 2-AAF feeding, but also to the same degree for at least 2 weeks after cessation of carcinogenic insult. Dot blot analysis showed HGF transcripts to be elevated after PH and during the selective growth conditions of 2-AAF feeding, dropping after cessation of carcinogenic insult. In the c-met transcript case transient increases were observed after PH, followed by a decrease. c-met over-expression in nodular livers did not correlate with the presence of 2-AAF or lesion development. In most hepatocellular carcinoma samples expression of both HGF and c-met mRNAs was below levels in non-neoplastic regions. These data suggest that HGF and c-met are directly involved in a paracrine growth pathway controlling proliferation in normal hepatocytes and oval cells, but not in preneoplastic and neoplastic cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8565131     DOI: 10.1093/carcin/17.1.19

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  3 in total

1.  Gene expression profile related to the progression of preneoplastic nodules toward hepatocellular carcinoma in rats.

Authors:  Julio Isael Pérez-Carreón; Cristina López-García; Samia Fattel-Fazenda; Evelia Arce-Popoca; Leticia Alemán-Lazarini; Sergio Hernández-García; Véronique Le Berre; Sergueï Sokol; Jean Marie Francois; Saúl Villa-Treviño
Journal:  Neoplasia       Date:  2006-05       Impact factor: 5.715

Review 2.  Genetically modified animal models recapitulating molecular events altered in human hepatocarcinogenesis.

Authors:  Aránzazu Sánchez; Isabel Fabregat
Journal:  Clin Transl Oncol       Date:  2009-04       Impact factor: 3.405

3.  Sparse distribution of hepatocyte growth factor-producing cells inside hepatocellular foci in rats treated with hepatocarcinogens.

Authors:  T Imai; M Ichinose; T Yanai; T Masegi; T Nakamura; T Tsukamoto; K Kitoh; M Tatematsu
Journal:  Jpn J Cancer Res       Date:  1997-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.